Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infection

Published:2020 Issue:4 Volume:15 Page:139-145
ISSN:1880-487X
Container-title:Journal of Rural Medicine
language:en
Short-container-title:J Rural Med

Author:

Watanabe Shunji¹,Morimoto Naoki¹,Miura Kouichi¹,Murohisa Toshimitsu²,Tahara Toshiyuki³,Sato Takashi⁴,Tano Shigeo⁵,Fukaya Yukimura⁶,Kurata Hidekazu⁷,Okamura Yukishige⁸,Numao Norikatsu⁹,Uehara Keita¹⁰,Murayama Kozue¹¹,Nakazawa Katsuyuki¹²,Sugaya Hitoshi¹³¹⁴,Yoshizumi Hiroaki¹⁵,Iijima Makoto²¹⁶,Tsukui Mamiko¹,Hirosawa Takuya¹,Takaoka Yoshinari¹,Nomoto Hiroaki¹,Maeda Hiroshi¹,Goka Rie¹,Isoda Norio¹,Yamamoto Hironori¹

Affiliation:

1. Department of Medicine, Division of Gastroenterology, Jichi Medical University, Japan

2. Department of Gastroenterology, Dokkyo Medical University, Japan

3. Department of Gastroenterology, Saiseikai Utsunomiya Hospital, Japan

4. Department of Gastroenterology, Nasu Red Cross Hospital, Japan

5. Department of Gastroenterology, Shin-Oyama City Hospital, Japan

6. Department of Internal Medicine, Nasu Minami Hospital, Japan

7. Department of Gastroenterology, Tochigi Medical Center Shimotsuga, Japan

8. Department of Gastroenterology, Sano Kousei General Hospital, Japan

9. Department of Gastroenterology, Haga Red Cross Hospital, Japan

10. Department of Gastroenterology, Tochigi Medical Center, Japan

11. Department of Gastroenterology, Koga Red Cross Hospital, Japan

12. Department of Gastroenterology, JCHO Utsunomiya Hospital, Japan

13. Department of Internal Medicine, Utsunomiya Higashi Hospital, Japan

14. Department of Gastroenterology, Ashikaga Red Cross Hospital, Japan

15. Department of Internal Medicine, Kamitsuga General Hospital, Japan

16. Department of Gastroenterology, Yuai Memorial Hospital, Japan

Publisher

Japanese Association of Rural Medicine

Link

https://www.jstage.jst.go.jp/article/jrm/15/4/15_2020-004/_pdf

Reference23 articles.

1. 1. Kanda T , Lau GKK , Wei L , et al. APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatol Int 2019; 13: 649–661.

2. 2. Tanaka J , Akita T , Ko K , et al. Epidemiological Research Group on Viral Hepatitis and its Long -term Course, Ministry of Health, Labour and Welfare of JapanCountermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res 2019; 49: 990–1002.

3. 3. Ebinuma H , Saito H , Tada S , et al. Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score. Hepatol Int 2012; 6: 744–752.

4. 4. Honda T , Katano Y , Shimizu J , et al. Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C. Liver Int 2010; 30: 527–537.

5. 5. Tanaka J , Akita T , Ohisa M , et al. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J Viral Hepat 2018; 25: 363–372.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life;Tropical Medicine and Infectious Disease;2023-11-18

2. Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study;Liver International;2023-04-30

3. Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid;Viruses;2023-02-09

4. Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older;BMC Gastroenterology;2022-04-28

5. Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection;Hepatology Research;2020-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3